Health
Oxford/AstraZeneca COVID-19 vaccine strongly efficacious in older adults – The Science Board
Similar safety and immunogenicity profiles were observed in adults and older adults who received the Oxford/AstraZeneca SARS-CoV-2 vaccine candidate, ChAdOx1 nCoV-19,…
A safe and effective vaccine that protects against SARS-CoV-2 infection is an important tool in controlling the global spread of the virus. Given that severe COVID-19 is more common in adults ages 70 years and older, a vaccine that targets this group of individuals in a safe and efficacious manner is desirable. Older adults are affected by immunosenescence, or the gradual decline of immune responses. Therefore, assessment of immune responses with careful regard to this susceptible group is essential…
-
Noosa News15 hours agoBondi Beach terror attack: Police investigate threat against Westfield North Lakes in Queensland
-
General22 hours agoCoalition ‘flabbergasted’ by Labor’s response to calls for royal commission into antisemitism
-
Business16 hours ago3 ASX ETFs that could be perfect for beginners
-
General13 hours agoQueensland mother accused of staging drowning death of four-year-old son committed to stand trial